P. T. Dawes

4.2k total citations
100 papers, 3.0k citations indexed

About

P. T. Dawes is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, P. T. Dawes has authored 100 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Rheumatology, 16 papers in Immunology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in P. T. Dawes's work include Rheumatoid Arthritis Research and Therapies (58 papers), Systemic Lupus Erythematosus Research (20 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). P. T. Dawes is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (58 papers), Systemic Lupus Erythematosus Research (20 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). P. T. Dawes collaborates with scholars based in United Kingdom, United States and Australia. P. T. Dawes's co-authors include Derek L. Mattey, Nicola B Nixon, Andrew Hassell, P D Fowler, Peter M. Jones, John R. Glossop, M F Shadforth, Ann Brownfield, William Ollier and Ali H. Hajeer and has published in prestigious journals such as Annals of the Rheumatic Diseases, Statistics in Medicine and Intensive Care Medicine.

In The Last Decade

P. T. Dawes

99 papers receiving 2.9k citations

Peers

Countries citing papers authored by P. T. Dawes

Since Specialization

Citations

This map shows the geographic impact of P. T. Dawes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. T. Dawes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. T. Dawes more than expected).

Fields of papers citing papers by P. T. Dawes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. T. Dawes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. T. Dawes. The network helps show where P. T. Dawes may publish in the future.

Co-authorship network of co-authors of P. T. Dawes

This figure shows the co-authorship network connecting the top 25 collaborators of P. T. Dawes. A scholar is included among the top collaborators of P. T. Dawes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. T. Dawes. P. T. Dawes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reconsultation, self-reported health status and costs following treatment at a musculoskeletal Clinical Assessment and Treatment Service (CATS): a 12-month prospective cohort study 2016 ·BMJ Open ·Edward Roddy, Kelvin P. Jordan, Raymond Oppong, Ying Chen, Sue Jowett, P. T. Dawes, Samantha Hider, Jon Packham, K. Stevenson, Irena Zwierska, Elaine M. Hay	2
2	Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: a cross-sectional study 2012 ·Arthritis Research & Therapy ·Ying Chen, P. T. Dawes, Jon Packham, Derek L. Mattey	24
3	Interaction Between Smoking and Polymorphism in the Promoter Region of the VEGFA Gene Is Associated with Ischemic Heart Disease and Myocardial Infarction in Rheumatoid Arthritis 2011 ·The Journal of Rheumatology ·Ying Chen, P. T. Dawes, Jon Packham, Derek L. Mattey	31
4	Relationship Between Pack-year History of Smoking and Response to Tumor Necrosis Factor Antagonists in Patients with Rheumatoid Arthritis 2009 ·The Journal of Rheumatology ·Derek L. Mattey, Ann Brownfield, P. T. Dawes	73
5	Does the North Staffordshire slot system control demand of orthopaedic referrals from primary care?: A population-based survey in general practice. 2005 ·PubMed ·Stephen Bridgman, Xuefang Li, Gilbert MacKenzie, P. T. Dawes	8
6	Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs—results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial 2005 ·Lara D. Veeken ·Deborah Symmons, K. Tricker, Mark Harrison, (unknown), M Davis, P. T. Dawes, Andrew Hassell, Susan Knight, D. Mulherin, David L. Scott	37
7	Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease 2004 ·Annals of the Rheumatic Diseases ·Derek L. Mattey, P. T. Dawes, Nicola B Nixon, (unknown), (unknown), George D. Kitas	15
8	Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index. 2003 ·PubMed ·Kirstie Haywood, Andrew Garratt, Krysia Dziedzic, P. T. Dawes	66
9	HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. 2001 ·PubMed ·Derek L. Mattey, P. T. Dawes, Miguel Á. González‐Gay, Carlos García‐Porrúa, Wendy Thomson, Ali H. Hajeer, William Ollier	58
10	Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis 2001 ·Arthritis & Rheumatism ·Derek L. Mattey, Andrew Hassell, P. T. Dawes, (unknown), Kay Poulton, Wendy Thomson, Ali H. Hajeer, William Ollier	54
11	Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: Influence on disease outcome 1999 ·Arthritis & Rheumatism ·Derek L. Mattey, Andrew Hassell, P. T. Dawes, William Ollier, Ali H. Hajeer	29
12	Management of oral complications of disease-modifying drugs in rheumatoid arthritis 1997 ·Lara D. Veeken ·(unknown), Michael Plant, Andrew Hassell, M F Shadforth, Jolene H. Fisher, Shane Clarke, (unknown), P. T. Dawes	8
13	Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus 1994 ·Clinical Rheumatology ·Andrew Borg, Martin J. Davis, P. T. Dawes, M F Shadforth	1
14	An index of disease activity in rheumatoid arthritis 1993 ·Statistics in Medicine ·Peter M. Jones, Fouad Ziade, Martin J. Davis, P. T. Dawes	2
15	Rheumatoid arthritis: an association with pemphigus foliaceous. 1992 ·Acta Dermato Venereologica ·Mark Wilkinson, Andrew G. Smith, Martin J. Davis, K Hollowood, P. T. Dawes	8
16	COMPARISON AND EVALUATION OF A DISEASE ACTIVITY INDEX FOR USE IN PATIENTS WITH RHUEMATIOD ARTHRITIS 1990 ·Lara D. Veeken ·Martin J. Davis, P. T. Dawes, P D Fowler, Thomas Sheeran, M F Shadforth, Fouad Ziade, Michael P. Collins, Peter M. Jones	33
17	ELISA assays for IgM and IgG rheumatoid factors: Their clinical correlations during therapy with slow-acting anti-rheumatic drugs 1987 ·Clinical Rheumatology ·David L. Scott, P. T. Dawes, Mary Collins, (unknown)	8
18	THE RELATIONSHIP BETWEEN THE COMPLEX OF IMMUNOGLOBULIN A AND ALPHA-1-ANTITRYPSIN, ITS CONSTITUENT COMPONENTS AND THE ACUTE-PHASE RESPONSE AS MEASURED BY C-REACTIVE PROTEIN IN RHEUMATOID ARTHRITIS TREATED WITH GOLD OR D-PENICILLAMINE 1987 ·Lara D. Veeken ·P. T. Dawes, R A Jackson, M F Shadforth, (unknown), D.R. Stanworth	10
19	Availability of non-steroidal anti-inflammatory drugs over the counter: information needed. 1984 ·BMJ ·P. T. Dawes, P D Fowler, M F Shadforth, (unknown)	2
20	Changes in the conditiond avoidance behaviour of rats following the administration of drugs to the amygdala [proceedings]. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·P. T. Dawes, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact